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Rapport de synthèse 
La prévalence de l'hypertension artérielle, d'une dyslipidémie, d'une obésité et d'un 
tabagisme est élevée chez les patients qui souffrent d' une maladie coronarienne familiale 
précoce (MC-FP). Le but de cette étude fut d'investiguer la prévalence de ces facteurs de 
risque cardiovasculaires au sein des membres d'une famille dont un patient est affecté d'une 
MC-FP. 
Nous avons étudié 108 familles différentes dont au minimum 2 frères/sœurs ont survécu à une 
maladie coronarienne précoce. Cette dernière fut définie par la survenue d'un événement 
coronarien avant l'âge de 51 ans pour les hommes et 56 ans pour les femmes. Au total, nous 
avons identifié 222 patients atteints de MC-FP chez qui 158 frères/ sœurs, 197 enfants et 94 
époux/ épouses ne souffraient pas de maladie coronarienne. Ces parents proches furent 
comparés à un collectif d'individus« contrôles» issus de la population générale. 
Les frères/sœurs non affectés avaient une prévalence plus élevée d'hypertension artérielle 
(49% versus 24%, p<0.001), d'hypercholestérolémie (47% versus 34%, p=0.002), d'obésité 
abdominale (35% versus 24%, p=0.006) et de tabagisme (39% versus 24%, p=0.001) par 
rapport aux individus issus de la population générale. 
Parmi les enfants, une prévalence plus élevée d'hypertension artérielle fut identifiée chez les 
femmes, et une prévalence plus élevée d'hypercholestérolémie et d'obésité abdominale dans 
les deux sexes par rapport aux contrôles de la population générale. 
Aucune différence parmi les facteurs de risque cardiovasculaire n'a été observée entre les 
époux/ épouses et les contrôles. 
Les frères/ sœurs affectés et non affectés par la MC-FP ont également été comparés entre eux. 
La prévalence des facteurs de risque était similaire dans les 2 groupes, sauf pour le tabagisme, 
qui avait une prévalence plus élevée chez les frères/sœurs affectés (76% versus 39%, 
p=0.008). 
La prévalence de l'hypertension artérielle, de l'obésité, et de la dyslipidémie est également 
élevée chez les parents de premier degré de patients atteints de MC-FP, mais pas chez leurs 
époux/épouses. Ces personnes-là requièrent donc une attention médicale particulière en raison 
d'une vulnérabilité familiale et/ou génétique augmentée aux anomalies métaboliques 
athérogènes. Dans ces familles, le tabagisme pourrait être le facteur déclenchant de la MC-FP. 
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Abstract 
Background: Hypertension, hypercholesterolemia, obesity and smoking are highly prevalent among patients with familial premature coronary 
artery disease (FP-CAD). Whether these risk factors equally affect other family members remains unknown. 
Methods: We examined 222 FP-CAD patients, 158 unaffected sibs, 197 offspring and 94 spouses in 108 FP-CAD families (?:2 sibs having 
survived CAD diagnosed before age 51 (M)/56 (F)), and compared them to population contrais. 
Resu/ts: Unaffected sibs had a higher prevalence of hypertension (49% versus 24%, p < 0.001), hypercholesterolemia (47% versus 34%, 
p=0.002), abdominal obesity (35% versus 24%, p=0.006) and smoking (39% versus 24%, p=0.001) than population controls. Offspring 
had a higher prevalence of hypertension (females), hypercholesterolemia and abdominal obesity than population contrais. No difference was 
observed between spouses and contrais. Compared to unaffected sibs, FP-CAD affected sibs had a similar risk factor profile, except for 
smoking, which was more prevalent (76% versus 39%, p = 0.008). 
Conclusions: Hypertension, obesity and hypercholesterolemia are highly prevalent among first-degree relatives, but not spouses, of patients 
with FP-CAD. These persans deserve special medical attention due to their familial/genetic susceptibility to atherogenic metabolic abnor-
malities. In these families, smoking may be the trigger for FP-CAD. 
© 2006 Elsevier Ireland Ltd. Ali rights reserved. 
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1. Introduction 
Coronary artery disease (CAD) has a familial compo-
nent, and first-degree relatives of CAD patients are at higher 
risk for cardiovascular diseases than the general population 
[ 1-4]. Twin studies indicate that this familial component 
is partly genetic, and that the genetic contribution to CAD 
is mostly apparent in premature forms of the disease [5]. 
Mendelian forms of dyslipidemia, such as familial hyper-
cholesterolemia [6] or rare genetic mutations like the one 
reported in the MEF2A gene [7], only account for a small 
fraction of premature CAD cases, so that genes contribut-
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ing to common forms of premature CAD remain to be 
identified. 
GENECARD is a family-based study designed to identify 
susceptibility genes to familial premature CAD (FP-CAD). In 
GENECARD, a total of 850 sib-pairs who had survived pre-
mature CAD diagnosed before the age of 51 years for males 
and 56 years for females have been recruited in six different 
centres located in North America and Europe [8], including 
sib-pairs from 108 families from the Lausanne accrual centre 
in Western Switzerland [9]. Given the young age eut-offs and 
the fact that at least two sibs were affected in these families, 
it was anticipated that the genetic contribution to the disease 
should be particularly pronounced in the GENECARD col-
lection. 
Detailed analysis of the cardiovascular risk factor profile in 
FP-CAD affected sib-pairs recruited in Lausanne established 
that the prevalence of hypertension, hypercholesterolemia, 
obesity and smoking was approximately twice as high in these 
individuals as compared to the general population. Moreover, 
it revealed a strong concordance between affected sibs for 
these conditions, suggesting that FP-CAD is, at least partly, 
due to an increased familial, possibly genetic, susceptibility to 
atherogenic metabolic disorders, and to smoking [9]. Because 
these risk factors are remediable, their detection in apparently 
healthy family members was deemed necessary. Accordingly, 
we designed the present study to investigate the prevalence 
of major cardiovascular risk factors in first-degree relatives 
(i.e. sibs and offspring) and spouses of FP-CAD patients. 
2. Methods 
The design of the GENECARD project [8] and the way 
sib-pairs who had survived FP-CAD were ascertained in Lau-
sanne, Switzerland, area for this project have previously been 
described [9]. Briefly, a total of 103 patients with one sib who 
had equally survived premature CAD, four patients with two 
affected sibs and one patient with three affected sibs were 
recruited in the Lausanne area, totalizing 222 (180 M/42 F) 
FP-CAD affected persons from 108 sibships. 
These persons were asked permission to contact their 
spouse, their offspring aged '.'::: 18 years and their sibs who did 
not meet the affection status for GENECARD, i.e. they did 
not meet clinical criteria for FP-CAD. These individuals were 
contacted and were asked to participate in the project after 
having been fully informed about the study. The protocol was 
approved by the local Ethics Committee. Participation rate 
for unaffected sibs and offspring was approximately 70%, 
the remaining individuals declining to participate mostly due 
to geographical reasons and, more rarely, for lack of interest 
in this project. Spouses were only asked to participate in the 
study if they were of Caucasian origin and if they had chil-
dren eligible for the study (i.e. aged 18 or older). Participation 
rate for spouses was 79%. Participants were recruited during a 
visit by the investigators to their home where they were asked 
to fill in a detailed questionnaire and they underwent a limited 
physical examination. Blood pressure was measured in sitting 
position after a 10-min rest using the lntellisense automatic 
sphygmomanometer (OMRON, Steinhausen, Switzerland) 
which had been previously validated [IO]. Blood was col-
lected after a > 12 h fast and was immediately put on ice and 
stored refrigerated until processed. Total cholesterol levels 
were measured in these samples using the enzymatic CHOD-
PAP method (Sorachim, Le Mans, France). Participants in the 
present study were ail recruited between 1999 and 2001. 
Each participant within the 25-74 age range was matched 
to three individuals of same sex and age randomly selected 
among 3616 individuals who participated in two population-
based health examination surveys conducted in Western 
Switzerland (Cantons Vaud and Fribourg) in 1988-1989 
and 1992-1993 [11] within the framework of the interna-
tional multi-center MONICA project [ 12]. An allowance for 
a limited difference in age (maximum 3 years) was intro-
duced in the matching criteria in order to achieve a fixed 
case-control ratio of 1:3. In MONICA, blood pressure had 
been measured using a manual sphygmomanometer, and total 
cholesterol levels had been measured using the enzymatic 
method CHOD-PAP (Boehringer, Mannheim, Germany). To 
allow proper comparison of blood pressure measurements 
in the local MONICA and the present study, blood pressure 
was measured in 67 participants of the present study using 
both a manual and the Omron sphygmomanometer. A high 
correlation was observed between the two types of measure-
ments for both systolic and diastolic blood pressure (r2 = 0.91 
and 0.78, respectively), and linear regression was used to 
adjust the MONICA pressure readings for differences in the 
measurement methods. Similarly, 30 samples were randomly 
drawn from the MONICA serum repository and re-assayed 
for total cholesterol using the same laboratory and method 
as in the GENECARD project. A r2 = 0.65 correlation was 
observed between these values, and again a linear regression 
was used to adjust the MONICA total cholesterol values. 
Body mass index (BMI) were not used in the present com-
parison, as height was self-reported (i.e. not measured) in 
GENECARD. However, we i.Ised waist circumference as a 
marker for abdominal obesity, as this parameter had been 
measured similarly in both projects. The presence of dia-
betes had not been recorded in the MONICA survey, so this 
variable was not included in the present analysis. 
FP-CAD affected sibs were included in part of the anal-
yses. Because some of these individuals had substantially 
changed their habits after they had been diagnosed with 
FP-CAD (for example, 55% of those who were smokers 
when diagnosed with CAD had stopped smoking by the 
time they were ascertained in GENECARD), data recorded 
in medical records at the time the diagnosis was originally 
made were used in these analyses, as described previously 
[9]. 
A substantial proportion of participants and controls, 
mostly in the parental generation (sibs and spouses), were 
receiving antihypertensive or lipid-lowering drugs, limiting 
the use of continuous traits and prompting us to use cat-
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egorical variables. Because blood pressure, waist circum-
ference and plasma cholesterol levels increase with age, 
we used separate definitions for hypertension, abdominal 
obesity and hypercholesterolemia for the parental and the 
offspring generations. Hypertension in the parental genera-
tion was operationally defined by the presence of systolic 
and/or diastolic blood pressure 2: 160/95 mmHg and/or pre-
scription of antihypertensive agents whereas lower thresholds 
(2: 140/90 mmHg) were applied to the offspring generation. 
Similarly, plasma total cholesterol levels 2: 6.5 mmol/L, or 
prescription of lipid lowering agents, were used to define 
hypercholesterolemia in the parental generation, whereas 
2:_5.2mmol/L was used as a threshold for the offspring. 
Abdominal obesity was defined as waist circumference 
2: 102 cm for males and 2:88 cm for females in the parental 
generation, and 2:94 cm for males and 2:_80 cm for females in 
the offspring generation. Because this value was frequently 
missing for FP-CAD affected sibs at the time of diagnosis, 
abdominal obesity was defined as BMI 2: 25 kg/m2 for this 
particular group. Smoking was defined for both generations 
as active cigarette smoking at the time of recruitment, or at 
the time of event for FP-CAD individuals, or within the 5 
preceding years. 
The GENECARD project was initiated and sponsored 
by GlaxoSmithKline, which funded the recruitment and the 
collection of data and samples from FP-CAD affected sib-
pairs. GlaxoSmithKline was not involved in the recruitment 
of unaffected family members or in the design of the present 
study. The corresponding author of this manuscript (VM) 
joined GlaxoSmithKline as a full-time employee after the 
recruitment was completed and during the analysis of the 
data. Submission of this manuscript was approved by Glax-
oSmithKline. 
Data are expressed as mean ± S.D. Conditional logistic 
regression for case-control studies [ 13] was used to calcu-
late the odds ratios (ORs) and their confidence intervals for 
the various cardiovascular risk factors. Concordance for the 
Table 1 
Clinical characteristics of the participants and their contrais 
Unaffected sibs Contrais p 
Il 158 474 
Gender, M/F (%M) 69/89 (44) 207/267 (44) NS" 
Age, years (S.D.) 54.5 (8.1) 54.5 (8.1) NS" 
Systolic blood pressure, mmHg (S.D.) 138.8 (23.4) 137.2 (20.1) NS 
Diastolic blood pressure, mmHg (S.D.) 86.6 (12.5) 82.5 (12.2) <0.001 
Antihype1tensive treatment (%) 36 (23) 47 (10) <0.001 
Hypertension (%)h 77 (49) 114 (24) <0.001 
Total cholesteral, mmol/L (S.D.) 5.69 (1.05) 5.69 (1.39) NS 
Lipid lowering therapy (%) 46 (29) 38 (8) <0.001 
Hypercholesteralemia (%)h 74 (47) 161 (34) 0.002 
Waist circumference, cm 91.4 (12.1) 88.5 (10.2) 0.008 
Abdominal obesity (% )b 55 (35) 114 (24) 0.006 
Smoking (%)h 61 (39) 115 (24) 0.001 
NS, not significant, p > 0.20. 
" Criteria used for matching. 
b As operationally defined in Section 2. 
presence of risk factors in FP-CAD affected persons and their 
family members was examined using kappa tests. Statistical 
analyses were carried out using STATA (release 6.0, Stata 
Corp, College Station, TX) and SPSS (release 4.0, SPSS, 
Inc., Chicago, IL). 
3. Results 
A total of 222 FP-CAD affected sibs, 158 unaffected sibs, 
94 spouses and 197 offspring of FP-CAD individuals were 
ascertained in the present study. A full description of these 
individuals and the pedigrees are provided in Appendix A. 
The clinical characteristics of the participants, as well as those 
of the age- and sex-matched controls from the local MONICA 
population, are described in Table 1. 
3.1. Risk factor profile in unaffected sibs 
Sibs ofFP-CAD individuals had, compared to their respec-
tive population controls, a similar systolic, but a higher dias-
tolic blood pressure. A larger proportion of these sibs received 
anti-hypertensive agents, so that blood pressure levels in 
these individuals were probably underestimated. Overall, the 
prevalence of hypertension was twice as high in unaffected 
sibs compared to their controls. Similarly, total cholesterol 
levels did not differ between the two groups. However, the 
proportion of sibs receiving lipid-lowering agents was signifi-
cantly larger than for controls, so that the prevalence ofhyper-
cholesterolemia was higher in unaffected sibs. Moreover, 
these sibs had a higher waist circumference, and the propor-
tion of individuals with abdominal obesity was significantly 
higher in this group. Finally, smoking was also more prevalent 
in sibs than in controls. Overall, the cumulative number of the 
four risk factors under consideration was significantly higher 
in sibs than in controls [1.7 ± 1.0 (S.D.) versus 1.1±0.9, 
p < 0.001]. Conversely, the proportion of individuals with 
Spouses Contrais p Offspring Contrais p 
94 282 197 591 
15179 (16) 45/237 (16) NS" 100/97 (51) 300/291 (51) NS" 
55.6 (5.7) 55.7 (5.7) NS" 32.3 (5.3) 32.3 (5.3) NS" 
132.3 (20.0) 137.7 (18.9) 0.023 122.2 (13.6) 123.8 (14.9) 0.164 
83.3 (11.7\ 82.9 (12.1) NS 79.1 (11.1) 75.9 (11.5) <0.001 
20 (21) 34 (12) 0.043 2 (1) 6 (!) NS 
31 (33) 76 (27) NS 39 (20) 112 (19) NS 
5.72 (0.93) 5.77 (1.39) NS 5.21 (1.09) 4.76 (1.31) <0.001 
7 (7) 23 (8) NS 10 (5) 6 (!) 0.001 
24 (25) 99 (35) 0.091 99 (50) 207 (35) <0.001 
87.4 (14.3) 85.0 (9.6) 0.143 83.6 (11.4) 81.0 (9.0) 0.005 
31 (33) 90 (32) NS 56 (28) 88 (15) <0.001 
30 (32) 68 (24) 0.127 83 (42) 260 (44) NS 
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Table 2 
Concordance of cardiovascnlar risk factors between participants in the stndy 
Risk factor Agreement Between FP-CAD affected sib and 
Unaffected sib (202)" Sponse (69)" Child (134)" 
Observed agreement(%) 57.9 53.6 57.5 
Hypertension Expected agreement (o/o)h 50.4 51.5 52.5 
Kappa coefficient (p) 0.15 (0.015) 0.04 (0.35) 0.11 (0.082) 
Observed agreement(%) 60.9 43.5 62.7 
Hypercholesteralemia Expected agreement (o/o)b 50.1 43.0 49.7 
Kappa coefficient (p) 0.22 (0.001) 0.01 (0.46) 0.26 (0.001) 
Observed agreement(%) 45.1 49.2 47.8 
Abdominal obesity Expected agreement (% )11 43.2 44.1 42.1 
Kappa coefficient (p) 0.03 (0.26) 0.09 (0.16) 0.10 (0.06) 
Observed agreement(%) 49.5 58.0 50.0 
Smoking Expected agreement (o/o)h 45.4 44.6 46.7 
Kappa coefficient (p) 0.08 (0.10) 0.24 (0.006) 0.06 (0.22) 
a Nnmber of pairs. 
b Expected agreement obtained when assnming independence of risk factor distribution between FP-CAD affected sib and their family members. This analysis 
was restricted to family members of FP-CAD individnals for whom the cardiovascnlar risk profile was known at event. 
none of these conditions was twice as low among sibs (15% 
versus 31%,p<0.001). Using conditional logistic regression 
analysis, the risk was significantly increased for unaffected 
sibs compared to population controls of having hyperten-
sion [OR 3.6 (95% CI 2.3-5.4)], hypercholesterolemia [1.8 
(l.3-2.6)], abdominal obesity [1.6 (l.2-2.6)] and smoking 
[2.0 (1.4-3.0)]. These ORs were similar to those previously 
observed when comparing FP-CAD individuals to matched 
controls from the general population for hypertension [ 4.6 
(3.0-7.0), p=0.18] or hypercholesterolemia [2.7 (l.9-3.9), 
p = 0.09]. In contrast, the OR for smoking was significantly 
higher for FP-CAD individuals [4.2 (2.8-6.3)] than for their 
unaffected sibs (p = 0.008). Direct comparison of ORs was 
100% 
Hypertension 100% Hypercholesterolemla 
OR=4.T*** 
Il 
75% 72% 75% 
OR=2.3* OR•1.5':' 
OR.,3.5*** Il Il ~ 5.5% Il 54% 
Ql 49% ü 50% 50% 
c OR=1.7 44% Ql 
Cii 37% Il 
> OR=2.4* 34% 35% [l! Il 
o... 26% 
25% 23% 25% 22% 
13% 
0% 0% 
not possible for obesity because of different methods of mea-
surement (see Section 2). 
To further explore the architecture of cardiovascular risk 
factors in these families, we next examined the concordance 
of major risk factors between FP-CAD affected patients, 
their unaffected sibs, their offspring and their spouses 
using kappa tests (Table 2). In this analysis, the agreement 
observed between FP-CAD patients and their sibs was higher 
than expected for hypertension and hypercholesterolemia, 
but was similar to the expected one for abdominal obesity 
and smoking. 
The difference in the prevalence of risk factors between 
unaffected sibs and their controls was partly age-dependent 
100% Abdominal obeslty 100% Smoking 
75% 75% 
OR=2.5* 
OR=1.5* Il 
Il 51% OR=2.0'~ 
50% 45% 50% 
OR=2.3* Il 
OR•2.8* Il 37% 39% OR=1.6 
Il 31% 31% Il 26% 
24% 26% 25% 25% 
18% 
'5% 
0% 0% 
33-50y 51-5By 59y+ 33-50y 51-58y 59y+ 33-50y 51-58y 59y+ 33-50 51-58 59+ 
Age Tertiles (years) 
Fig. 1. Prevalence rates and odds ratios (OR) for hype1tension, hypercholesteralemia, abdominal obesity and smoking among nnaffected sibs of FP-CAD 
patients (solid bars) and their age- and gender-matched population contrais (open bars), according to age te1tile. Hypertension, hypercholesteralemia and 
abdominal obesity were defined as described in Section 2. Total nnmber of nnaffected sibs and contrais was 158 and 474, respectively. Nnmber on top of 
colnmns indicate OR. *p <0.05, **p <0.01, *** p <0.001 vs. population contrais. 
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(Fig. 1 ). The prevalence of hypertension was approximately 
two-fold higher in unaffected sibs than in the general pop-
ulation for the three age tertiles. In contrast, the difference 
between unaffected sibs and controls was only significant in 
the second and third age tertiles for hypercholesterolemia, 
and in the first and second tertiles for smoking. Abdominal 
obesity was more prevalent in unaffected sibs than in controls 
for the three age tertiles, but the difference was particularly 
striking for the first tertile. 
3.2. Riskfactor profile in spouses 
Because FP-CAD is much more frequent in men, most 
spouses were females. Systolic blood pressure was lower in 
spouses than in their respective controls, but this difference 
may have been accounted for by the higher proportion of 
spouses who were treated for high blood pressure, so that the 
overall prevalence of hypertension was similar in spouses 
and in population controls (Table 1). Plasma levels of total 
cholesterol and waist circumference were similar in the two 
groups, and so was the prevalence of hypercholesterolemia, 
abdominal obesity and smoking. However, the prevalence of 
smoking was higher in individuals whose FP-CAD spouse 
was a smoker than in their respective controls [18/44 (42%) 
versus 23/132 (17%), OR 3.0 (1.5-6.4)]. These observa-
tions were reinforced by concordance analysis (Table 2). In 
this analysis, the concordance observed between FP-CAD 
patients and their spouses was similar to the one expected for 
hypertension, hypercholesterolemia and abdominal obesity, 
but was higher than expected for smoking. 
3.3. Riskfactorprofile in offspring 
The average age of the offspring was 32.3 ± 5.3 years 
(Table !). Offspring presented a similar systolic, but a higher 
diastolic blood pressure than their population contrais. The 
prevalence of blood pressure:'.'.'.: 160/95 mmHg was low in 
the offspring group and their contrais (8% versus 6%, NS), 
and no difference was observed either when a lower thresh-
old ( 140/90 mmHg) was used to define hypertension in this 
generation. When offspring were stratified based on gender, 
however, daughters, but not sons, had a higher prevalence of 
hypertension than their controls [9/48 (19%) versus 3/144 
(2%), OR 9.0 (2.4-33.2)]. Plasma total cholesterol levels 
were higher in offspring than in contrais. Overall, 12% of 
offspring and 10% of controls had plasma total cholesterol 
levels :'.'.'.: 6.5 mmol/L (NS). However, when using 5.2 mmol/L 
as a threshold to define hypercholesterolemia in this gen-
eration, the prevalence of hypercholesterolemia was signif-
icantly higher in offspring. Similarly, waist circumference 
was higher in offspring, and the proportion of offspring with 
abdominal obesity was twice as high as the one observed 
among controls. Smoking was equally prevalent in bath 
groups. Overall, the intra-individual sum of risk factors was 
1.9± 1.1 in offspring and 1.6± 1.1 in controls (p<0.001). 
In an attempt to identify which is the first detectable risk 
factor that differs between offspring of FP-CAD individuals 
and the general population, we stratified the offspring based 
on age tertile (Fig. 2). The prevalence of hypertension and 
smoking was similar between offspring and controls for the 
three age groups. In contrast, the prevalence of hypercholes-
terolemia and abdominal obesity was significantly higher in 
the three age groups. 
We next examined the transmission of the risk factors from 
parents to offspring. A total of 121 offspring had bath parents 
recruited in the present study. The risk of being hyperten-
sive, hypercholesterolemic or smoker was not increased if 
none of the parents were carriers. In contrast, if bath parents 
suffered from hypertension, hypercholesterolemia or obesity, 
the risk for the offspring was markedly increased. No such 
?S%,-~~-H-yp-e-rte-n-si-on~~~~ 7s%~~~Hy_p_er-ch_o_Jes-le-ro-Je-m-ia~~ 7s%.-~~A-bd_o_m_ina-J-ob-e-sify~~~ 75%.-~~~S-m-o-kin-g~~~~ 
~ 
Ql 
ü 
c 
Ql 
~ 
50% 
J: 25% 
0% 
OR=1.2 
OR=1.1 Il 
20% 
15% 15% 
1B'to 
25-29y 30-34y 
OR=1.1 
Il 
25% 24% 
35y+ 
50% 
25% 
0% 
OR=2.2* 
58% 
OR=1.9* 
41% 
37% 
28% 
25-29y 30-34y 
OR=1.7* 
52% 
50% 
40% OR=t.6* 
34% 
27% 
25% 
25% 25% 
14% 
6% 
0% 
35y+ 25-29y 30-34y 35y+ 
Age Tertiles (hears) 
50% OR=O.B 
39% 
34% 
25% 
0% 
25-29y 
OR=0.9 
Il 
50% 
48% 
30-34y 
OR=0.9 
4Jo/o 45% 
35y+ 
Fig. 2. Prevalence rates and odds ratios (OR) for hype1tension, hypercholesteralemia, abdominal obesity and smoking among offspring of FP-CAD patients 
(solid bars) and their age- and gender-matched population contrais (open bars), according to age tertile. Hype1tension, hypercholesteralemia and abdominal 
obesity were defined as described in Section 2. Total number of offspring and population contrais was 197 and 591, respectively. Number on top of columns 
indicate OR.* p < 0.05, ** p < 0.01, ***p < 0.001 vs. population contrais. 
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trend was observed for smoking, though (data not shown). 
In concordance analysis (Table 2), a strong and a borderline 
concordance was detected between FP-CAD affected par-
ent and offspring for hypercholesterolemia and abdominal 
obesity, respectively. Overall, the concordance observed for 
hypertension did notreach significance. However, after strati-
fication by gender, it appeared that the concordance was much 
higher for parent-daughters (kappa= 0.18,p = 0.028) than for 
parent-sons (kappa= 0.07, p = 0.297). No concordance was 
observed for smoking. 
4. Discussion 
Using a matching procedure with a reference population, 
we have previously shown that hypertension, hypercholes-
terolemia, obesity and smoking are highly prevalent among 
patients diagnosed with FP-CAD [9]. In the present study, we 
applied the same approach to investigate their first-degree 
relatives and spouses. We demonstrate that the prevalence 
of these four risk factors is equally high among unaffected 
sibs. We also show that the risk for hypercholesterolemia and 
hypertension was similarly elevated among FP-CAD patients 
and their unaffected sibs, but the prevalence of smoking 
was significantly higher in the former group. Moreover, we 
show that offspring, but not spouses, ofFP-CAD patients are 
at higher risk for hypercholesterolemia, abdominal obesity 
and hypertension (for daughters) than the general popula-
tion. In addition, we have detected a significant concordance 
for hypertension and hypercholesterolemia, but not smoking, 
between FP-CAD affected individuals and their first-degree 
relatives. Reciprocally, the only factor that was concordant 
between FP-CAD patients and their spouses was smoking. 
Altogether, these data are indicative of the presence of a 
strong and complex familial, in part genetic, susceptibility to 
abdominal obesity, hypertension and hypercholesterolemia 
in families with FP-CAD. In the presence of smoking, which 
in these families does not seem to be genetically determined 
as concordance was only observed between spouses, these 
conditions may then lead to the clinical manifestation of the 
disease (i.e. CAD). 
This data has immediate relevance for the prevention and 
clinical management of FP-CAD patients and their family 
members, and for our efforts in identifying the genetic basis 
of FP-CAD. Indeed, the data demonstrates that first-degree 
relatives of FP-CAD affected individuals are themselves at 
higher risk for CAD than the general population. The risk may 
be particularly high, as a positive family history may even 
amplify the risk associated with the conditions examined here 
[4]. Importantly enough, the four conditions under consider-
ation are remediable, and interventions to correct them have 
been shown to protect patients from the development of CAD. 
Accordingly, proper detection, evaluation and management 
of major cardiovascular risk factors is warranted in persons 
who have two sibs known to have premature CAD, and inter-
vention should be particularly aggressive considering the fact 
that siblings of patients with CAD are frequently overlooked 
in primary prevention of CAD [15]. Moreover, similar inter-
ventions are needed for individuals who have one parent and 
one uncle/aunt diagnosed with premature CAD. Considering 
the fact that these offspring already have an increased waist 
circumference, and the association between obesity and coro-
nary lesions in the youth [ 16], indications for interventions 
should be extensive in this group. Conversely, our data does 
not indicate that spouses of FP-CAD affected individuals are 
at higher risk for CAD than the general population, unless 
they smoke, obviously, which they are at higher risk for if 
their affected spouse is himself/herself a smoker. 
From a genetic perspective, this study indicates that a 
major contribution of genes acting independently from tra-
ditional risk factors to trigger the development of FP-CAD 
is unlikely. This does not rule out, however, the presence of 
rare gene variants responsible for the development of CAD 
in selected families, such as the MEF2A gene [7]. Moreover, 
it is conceivable that some susceptibility genes for FP-CAD 
develop their potential to trigger the occurrence of the dis-
ease in the presence of traditional risk factors. A series of 
linkage peaks, including peaks on chromosomes 1, 3, 5 and 
7 identified in a recent whole genome scan performed on 
the GENECARD collection [ 14], supports this hypothesis. 
Conversely, it is also possible that unaffected sibs carry 'pro-
tective' genes that prevent the occurrence of CAD in presence 
of atherogenic metabolic abnormalities. 
This study has some limitations. One is that only families 
of individuals who had survived FP-CAD were recruited, so 
that the data may be specific to less deadly forms of CAD. 
Another limitation is the fact that blood pressure and plasma 
total cholesterol levels had not been measured using the same 
methods in GENECARD and MONICA, and that appropriate 
corrections had to be made to the MONICA data. Finally, one 
cannot formally rule out a secular trend, as the MONICA 
measures used for controls had been taken between 1988 
and 1993, whereas the GENECARD families were recruited 
between 1999 and 2001. In this respect, the fact that spouses 
had a very similar risk factor profile as the general population 
is very reassuring. 
In conclusion, this data demonstrates a high prevalence 
of hypertension, hypercholesterolemia, obesity and smoking 
in families with FP-CAD, and the importance of a proper 
detection and management of these remediable conditions. 
Avoiding smoking may be particularly beneficial as smoking 
may trigger the clinical expression of CAD in these suscep-
tible families. 
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Appendix A 
Complete description of the 108 families (Fam) who were 
included in the present data set are shown in Fig. Al. 
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